ArticleCureus2025
Management and Repair of a Large Basal Cell Carcinoma With Associated Varicosities Draining Into the Right Internal Jugular Vein.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Basal cell carcinoma (BCC) is the most prevalent skin cancer and carries a favorable prognosis when treated early. Mohs micrographic surgery (MMS) is the standard of care for large BCCs greater than 2 cm on the trunk or extremities, given its ability to achieve a high cure rate while maximizing preservation of healthy tissue. While arborizing telangiectasias are a hallmark feature, locally advanced tumors may demonstrate more obvious varicosities that warrant more rigorous preoperative planning. Herein, we present a case of a large BCC on the upper back with pronounced varicosities draining into the right internal jugular vein treated with MMS. Preoperative imaging and clinical evaluation were important for ensuring treatment success in this locally advanced BCC. The tumor cleared in one stage, and a 14-month follow-up revealed no tumor recurrence and regression of the aberrant vascularization.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.